Pharming Group N.V. provided revenue guidance for 2024. For the period, the company expects total revenues between USD280 million and USD295 million (14% to 20% growth), with quarterly fluctuations expected.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.799 EUR | -1.84% | -5.45% | -22.55% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.55% | 597M | |
+42.60% | 748B | |
+33.55% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.91% | 245B | |
+8.88% | 211B | |
-4.05% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Pharming Group N.V. Provides Revenue Guidance for 2024